Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Nexium, Other Heartburn Drugs, Often Given To Newborns Despite Risks: Study May 3, 2016 Irvin Jackson Add Your Comments The findings of a new study indicates that infants are frequently given heartburn drugs, such as Nexium, Prilosec and Zantac, despite concerns about potential health risks and evidence that suggests that may be no more effective than a placebo for newborns. Researchers from the Ohio State University College of Medicine and Nationwide Children’s Hospital found that in recent years, nearly one in four infants were given either proton pump inhibitors (PPIs), like Nexium and Prilosec, or histamine-2 receptor antagonists (H2RAs), like Zantac. The findings were published in the May issue of The Journal of Pediatrics. The study involved data on 122,002 infants treated at 43 children’s hospitals from January 2006 through March 2013. The data was taken from the Pediatric Health Information System database. Learn More About Nexium, Prilosec and Other Acid Reflux Drug Lawsuits Nexium, Prilosec and other acid reflux drug side effects may increase risk of kidney injury. Lawsuits reviewed. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Nexium, Prilosec and Other Acid Reflux Drug Lawsuits Nexium, Prilosec and other acid reflux drug side effects may increase risk of kidney injury. Lawsuits reviewed. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The study found that 23.8% of the newborns had received some type of heartburn drug, with 19% given H2RAs and 10.5% given PPIs. Infants most likely to receive the medications were those who were born extremely premature, and those with gastroesophageal reflux disease (GERD), congenital heart disease, and those with an ear, nose, and throat problem. The findings raise concerns following several studies that have questioned whether the drugs do any good, and many have indicated they carry a risk of sometimes severe side effects. In a 2011 report, researchers warned that the only controlled trials involving drugs like Nexium, Prilosec and Prevacid found that “PPIs have not been superior for symptom relief or histological healing” when compared to other heartburn drugs. “In Infants with irritability or regurgitation, several randomized, placebo-controlled trials and a systematic review conclude that PPIs are no more effective than placebo in improving symptoms,” the 2011 report found. In this latest study, the researchers warned that 56% of infants given heartburn drugs while in the hospital were still taking them at discharge. Overall, 75.7% of those given PPIs were still being given them at discharge, as well as 51.7% of those given H2RAs. “Our investigation demonstrates H2RAs/PPIs are frequently prescribed to neonates in US children’s hospitals often to discharge, despite a lack of published evidence for improved outcomes following their administration and increasing concerns for adverse effects,” the researchers noted. “Uncomplicated gastroesophageal reflux symptoms usually resolve by 12 months of age without treatment. The few available studies in preterm infants failed to show a reduction in symptoms clinically attributed to GERD following acid suppression.” Researchers also warned that there are concerns that gastric acid suppression could be harmful because stomach acidity in infants plays an important role in developing the defense against pathogens in the gastrointestinal tract. Previous studies have shown that H2RAs like Zantac have been linked to a higher risk of bloodstream infections in infants, they warned. The study comes amid growing concerns over the side effects of Nexium and other PPIs. Nexium Kidney Concerns In addition to Nexium, PPIs include some of the most widely used brand name medications in the United States, with Prilosec, Protonix, Prevacid, Dexilant, AcipHex and other treatments part of this class of medications. PPIs work by reducing the amount of acid in the stomach and are widely used by millions of Americans, since they are thought to carry few serious side effects. The FDA required a number of warning label changes for Nexium and other PPIs in December 2014, adding information for the first time about the risk of acute interstitial nephritis seen among users of the heartburn drugs. This condition involves inflammation that can lead to kidney injury or kidney failure if not promptly treated. In April 2015, a study published in the medical journal CMAJ Open found that in addition to acute interstitial nephritis, Nexium and other similar drugs may also increase risk of acute kidney injury, which involves an abrupt loss of kidney function. That research was followed by a study published earlier this year in the medical journal JAMA Internal Medicine, which found an increased risk of chronic kidney disease with use of proton pump inhibitors. That study suggested that users of Nexium, Prilosec and other heartburn drugs may face a 50% higher kidney disease risk when compared to non-users. Last month, yet another study published in the Journal of the American Society of Nephrology, found an increased risk of kidney failure and chronic kidney disease associated with long-term use of Nexium and other PPIs. Individuals throughout the United States are now pursuing potential Nexium lawsuits, Prilosec lawsuits and other acid reflux drug lawsuits over the kidney side effects associated with proton pump inhibitors. Plaintiffs allege that if warnings had been provided about the risk of acute interstitial nephritis, acute kidney injury, chronic kidney injury and kidney failure, many individuals may have been able to avoid these severe and potentially life-threatening injuries. Tags: Childrens Drugs, Kidney Damage, Nexium, Prevacid, Prilosec, Proton Pump Inhibitors, Zantac More Proton Pump Inhibitor Lawsuit Stories Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm April 15, 2024 Nexium, Prilosec Settlement Reached To Resolve Kidney Damage Lawsuits Against AstraZeneca October 4, 2023 Heartburn Drugs Like Nexium, Prilosec May Increase Risk of Serious Childhood Infections: Study August 17, 2023 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025) Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: 4 days ago) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)
Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm April 15, 2024
Nexium, Prilosec Settlement Reached To Resolve Kidney Damage Lawsuits Against AstraZeneca October 4, 2023
Heartburn Drugs Like Nexium, Prilosec May Increase Risk of Serious Childhood Infections: Study August 17, 2023
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: 4 days ago) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)